A preliminary analysis of U.S. FDA safety reports found that energy drinks and dietary supplements containing caffeine or other stimulants appeared disproportionately often in reports of serious cardiovascular problems. Among 28,345 reports submitted from 2017 to 2025, 854 involved stimulant products. Compared with reports about products without stimulants, these reports were about 11 times more likely to mention cardiac arrest and 4.5 times more likely to mention heart attacks. Ventricular arrhythmias or palpitations appeared roughly four times as often; rapid heartbeat, chest pain, and fainting were also reported more frequently. Adults aged 18 to 34 accounted for about 45% of the cardiovascular reports involving stimulant products, with similar patterns for men and women.
The findings identify a potential safety signal, not proof that the products caused the events or that consumers face those multiples of actual risk. Reports were submitted voluntarily, and researchers could not determine how many people used the products without problems or how many events went unreported. Other health conditions and behaviors, including intense exercise or mixing stimulants with alcohol or drugs, may also matter. The products vary widely in caffeine concentration, and some supplements contain far more caffeine than coffee. Researchers call for systematic safety monitoring and further study, while urging clinicians to ask younger patients with palpitations, chest pain, or fainting about stimulant use.
Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.